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ABSTRACT 
 
Superparamagnetic iron oxide nanoparticles (SPIONs) have emerged as promising contrast 
agents for Magnetic Resonance Imaging (MRI). Some SPIONs are already approved for 
clinical use. Coating of these nanoparticles with an additional biocompatible layer serves to 
improve the colloidal stability and biocompatibility. The present thesis is focused on the 
synthesis, characterization, and in vitro biocompatibility assessment of SPIONs as well as the 
assessment of the potential impact of the so-called bio-corona on the surface of these 
nanoparticles on their behavior. In addition, synthesis and magnetic evaluation of novel 
nanocomposites was also performed. 
 
In Paper I, the production of mono-dispersed, necking-free, single-core iron oxide-silica shell 
nanoparticles with tunable shell thickness was achieved by a carefully optimized inverse 
microemulsion method. The development of novel nanomaterials for biomedical applications 
need to be accompanied by careful scrutiny of their biocompatibility with a particular focus 
on the possible interactions with the primary defense system against foreign invasion, the 
immune system. Consequently, in Paper II, our efforts in synthesizing high quality core–shell 
nanoparticles with superparamagnetic character and sufficiently high magnetization were 
coupled with in vitro biocompatibility assessment and studies of cellular internalization using 
primary human macrophages and dendritic cells. The silica-coated nanoparticles were 
nontoxic to primary human monocyte-derived macrophages at all doses tested whereas dose- 
and size-dependent toxicity was observed for primary monocyte-derived dendritic cells 
exposed to smaller silica-coated nanoparticles, but not for the same-sized, commercially 
available dextran-coated iron oxide nanoparticles. Furthermore, the silica-coated iron oxide 
nanoparticles were taken up in both cell types through an active, actin cytoskeleton-
dependent process to a significantly higher degree when compared to the dextran-coated 
nanoparticles, irrespective of size. This has potentially useful implications for labeling of 
immune cells for visualization, diagnosis or treatment of inflammatory processes.  
 
When nanomaterials confront physiological media, the formation of a “corona” of proteins 
by adsorption to the surface of nanomaterials occurs which will influence how the particles 
will interact with a biological system and consequently will affect the fate of the particles. 
The potential effect of the protein corona on the magnetic and biological behavior of silica- 
versus dextran-coated SPIONs was addressed in Paper III. A thorough physical 
characterization of SPIONs without and with a protein corona as well as in vitro 
biocompatibility and cellular internalization using human primary macrophages was 
performed. Modulation of the magnetization and relaxivity signals of the SPIONs was noted 
following interaction with human plasma proteins. Macrophage viability was influenced by 
the presence or absence of a protein corona on silica-coated SPIONs but in the case of the 
dextran-coated SPIONs. Macrophage production of pro-inflammatory TNF-α was not 
triggered by SPIONs with or without a corona. Moreover, comprehensive assessment of the 
protein corona using mass spectrometry and bioinformatics tools revealed distinctive 
compositions on the two types of nanoparticles. Further studies need to be performed to 
understand the interrelationship between the acquired protein corona on the SPIONs and their 
function as MRI contrast agents. 
 
In Paper IV, incorporation of iron oxide nanoparticles homogeneously dispersed in a 
polymeric matrix and assessment of the magnetic and optical properties of the resulting 
structured nanomaterials are presented. Magnetic evaluation of the nanocomposite revealed 
its ferromagnetic properties while the low loading of nanoparticles with very good 
distribution in the nanostructure yielded materials with good magneto-optical properties. 
These materials have potential applications as micro actuators, sensors, relays and magneto 
optical devices based on the Faraday effect.  
 
Overall, this thesis attempts an interdisciplinary approach to the synthesis and 
characterization of nanomaterials and their biocompatibility assessment, with the aim to 
enable future applications in nanomedicine. 
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1 INTRODUCTION 
 
Nanostructured materials and more specifically nanoparticles have been a permanent 
encounter in everyday life of humans throughout the humankind history (1). The 
relationship started with the first tools fabrication were the particles and most probably, 
nanoparticles were accidentally inhaled. The discovery of fire, apart from a fantastic 
dietary improvement and other advantages, also brought along accidental inhalation of 
carbon nanoparticles produced by burning wood. The artists of the prehistoric age were 
exposed to iron oxide, manganese dioxide, charcoal, kaolin or mica nanoparticles in the 
attrition process of producing their pigments. Much later, the ancient Egyptians were 
exposed to lead nanoparticles from the make-up products. Silicosis affecting miners 
and stone workers, described already by ancient Greeks and Romans, is today known as 
an effect of long exposure to silica micro and nanoparticles.  
 
The 20
th
 century, especially after the Second World War, associated with an 
extraordinary development of techniques that could visualize small entities: 
Transmission Electron Microscope (TEM) – 1931, Scanning Electron Microscope 
(SEM) – 1935, Scanning Tunneling Microscope (STM) – 1985 and Atomic Force 
Microscope (AFM) - 1986. In addition, it brought an explosion of scientific interest in 
making smaller and smaller engineered features from bulk materials driven by the 
incentive of improving different areas of life as medicine, computer science, and energy 
storage. This correlated with a higher (and increasing) exposure of humans to 
nanoparticles to an unprecedented level in history either accidentally (environmental 
pollution, accidental work exposure) or through various products that contain 
nanoparticles: cosmetic products, clothes, medicines etc (2).  
 
This thesis is attempting an integral approach containing aspects related to synthesis of 
engineered nanoparticles and their biomedical applications as well as reflecting on to 
the impact of nanomaterials in biological systems. Understanding biological, 
toxicological effects of nanoparticles is crucial for the safe and sustainable development 
of nanomedicine (3). 
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1.1 NANOSTRUCTURED MATERIALS 
The term nano (from Greek nano meaning dwarf) is used for designating very small 
features, nano representing 10
-9
m. 
 
Often superimposed, the terms of nanostructures and nanostructured materials are 
complementary. Nanostructures are defined as entities characterized by form and at 
least one dimensionality in nanoscale range, while nanostructured materials are not 
only composed of building units having nanoscale dimensions but they are 
characterized additionally by composition (4, 5). In Table 1 are enumerated examples 
of the elementary building units of nanostructures. For the complete classification of 
the nanostructures that include 36 classes see the reference (5). 
 
Table 1. Elementary building units of nanostructures 
0D Fullerenes, nanorings, nanoparticles, core – shell nanoparticles, nanopowders, 
clusters 
1D Nanorods, fibers, filaments, nanotubes, spirals, nanowires, ribbons 
2D Nanofilms, nanomembranes 
 
The structures enumerated above are associated to sizes less the 100 nm that induces 
new physicochemical properties compared to the conventional formulations of the 
materials. The novel properties observed are attributed to their (i) morphology 
described by size induced effects (large surface area, narrow size distribution) and 
shape (spherical versus rod); (ii) controlled chemical composition: high purity, 
controlled crystallinity etc; (iii) surface structure: increased surface reactivity, inorganic 
or organic surface coatings; (iv) solubility and (v) aggregation versus colloidal stability.  
 
Figure 1 represents the inverse relationship between the particles size and the number 
of the molecules (or atoms) on the surface of a spherical nanoparticle. For sizes under 
100 nm the number of surface molecules increases exponentially with the decrease of 
the diameter. For a particle of 3 nm approximately 80% of its atoms/molecules are on 
the surface whereas for a nanoparticles of 30 nm diameter <10% of its constituents 
molecules are on the surface (2). 
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Figure 1. The diameter – surface molecules relationship for spherical particles (2) 
 
The same properties that lead to novel applications of nanomaterials in high end area as 
biomedical application, energy storing devices, computer industry might lead 
additionally to unique  (potentially hazardous) effects in biological systems (6, 7). In 
the next sections, we will review the specific applications of magnetic nanoparticles 
and magnetic nanocomposites related to the particular characteristics of magnetic 
nanoparticles. Additionally the safety assessment of possible exposure to nanoparticles 
is discussed and their possible toxicity associated to the interactions they might have 
with the biological environments.  
 
1.2 MAGNETIC NANOPARTICLES 
Two major magnetic iron oxide phases are used in medical applications: magnetite 
(Fe3O4) and maghemite (γ -Fe2O3). The preparation methods are critical in determining 
their properties: particle size and size distribution, shape, surface properties, magnetic 
properties, which are consequently influential on their applications (8).  
 
Iron oxide nanoparticles synthesis 
Numerous methods can be applied to synthesize magnetic iron oxide nanoparticles. The 
most commonly used methods are: co-precipitation, sol-gel synthesis, microemulsion 
synthesis, hydrothermal reactions, polyol method, thermal decomposition of precursors 
apart from less common techniques as spray and laser pyrolysis (9-11), electrochemical 
methods (12, 13) and flow injection synthesis (14). 
 
The co-precipitation method is probably the simplest one allowing the preparation of 
large quantities of nanoparticles in one batch. The iron oxides are prepared by mixing 
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ferrous and ferric salts in aqueous media (non oxidizing environment) at  high pH (15, 
16). The properties of precipitated iron oxides (incl. size, shape, composition) depend 
on the type of salts used as precursors (nitrates, sulfates, chlorides), molar ratio of the 
starting precursors, reaction temperature, pH and ionic strength of the media (17). 
Significant control on the size of the resulting particles can be achieved if during the 
formation of iron oxide nanoparticles chelating organic anions (carboxylate ions: citric, 
gluconic, oleic acid), or polymers as: polyvinyl alcohol (PVA), dextran, starch are 
added (18). 
 
Another method used for the synthesis of iron oxide nanoparticles is sol-gel technique. 
Sol-gel methods generally refer to the hydrolysis and condensation of metal alkoxides 
precursors that result in a colloid/“sol” of oxide nanoparticles. The ‘‘sol’’, by further 
condensation and polymerisation leads to a three dimensional network called “gel” 
containing the liquid phase (19). By subjecting the gels to elevated temperatures the 
nanoparticles acquire the final crystalline state. The properties of the gel are influenced 
by the solvent used, temperature, type of precursors utilized, pH and hydrodynamic 
conditions (8). This method is also suitable for production of large quantities of iron 
oxide nanoparticles. 
 
Water-in-oil microemulsions, called also inverse microemulsions, are alternatively used 
to obtain iron oxide nanoparticles with narrow size distribution and controlled 
morphology. The nanosized droplets of water dispersed in the oil phase and stabilized 
by surfactant molecules (at the oil/water interface) are confined environments limiting 
the growth in the formation process of the nanoparticles (20). Varying the size of the 
aqueous pool phase (or the ratio between the organic and water phase) is the main 
factor regulating the water droplet size and the iron oxide phase size. Other factors as 
reaction temperature, concentration of the reactants, flexibility of the surfactant film 
may also influence the final particles size (21-23).  
 
Another route used for synthesizing iron oxide nanoparticles is the hydrothermal 
method. This method is simple, versatile and environmentally friendly route  with no 
organic solvent involved and no post reaction treatment as calcination being necessary 
(24). The reactions are carried out in aqueous media at high pressures (>2000 psi) and 
elevated temperatures (200-300 C). The solvent content, temperature and time (25) 
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have important influence on the resulting nanoparticles by influencing the nucleation 
and growth processes.  
 
The polyol method is a facile method of synthesizing nanoparticles with well-defined 
size and shape, narrow size distribution compared with the aqueous route (26). The 
solvents (ex. ethylene glycol, diethylene glycol, polyethylene glycol) dissolve the 
inorganic precursors, but due to their high boiling point. Moreover they act as reducing 
agents and as stabilizing agents preventing the aggregation of newly formed particles 
(27). The obtained nanoparticles are easily dispersible in polar solvents being coated 
with a hydrophilic ligand. 
 
A high degree of monodispersity and a greater control on the size of the nanoparticles 
can be achieved using synthesis methods as high temperature decomposition of 
metallo-organic iron precursors. Iron oxide particles with well control on the size 
ranging from 4 to 20 nm (28-30) are obtained from the thermal decomposition of 
Fe(Cup)3, Fe(CO)5, Fe(acac)3 in the presence of surfactants. Using iron chloride salts or 
other iron oxides as precursors is a much more environmental friendly alternative and is 
becoming an increasingly used method for obtaining easily tunable size iron oxide 
nanoparticles (31-34). The nanoparticles obtained are well-separated, dispersible in 
organic solvent, various treatments being necessary to make these particles dispersible 
in water.  
 
Core shell nanoparticles synthesis. 
The core-shell nanoparticles are excellent candidates for increasing the intrinsic 
functionalities and building up progressively more complicated structures.  
 
The magnetic core can be used for targeting by an external field. In addition, it allows 
localization and visualization through MRI of the effects of the active substance 
incorporated in/adsorbed on the surface of the shell. Additionally, the magnetic core 
can be used as an alternative treatment modality via hyperthermia therapy.  
 
Silica offers an inert coating material on the magnetic core that inhibits their 
aggregation in liquid media, enhances their chemical stability and offers a versatile 
platform for surface modification. Furthermore, dye incorporation or quantum dots 
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inclusion into the shell adds an extra function of detection and localization under 
excitation using different wavelength of radiation.  
 
Silica coating methods.  
Silica is one of the most researched materials for coating magnetic and metallic 
nanoparticles. It increases the chemical stability and biocompatibility of the core 
particles as well as their colloidal stability by isolating the magnetic dipoles through the 
silica shell and inducing electrostatic repulsion (silica is negatively charged at 
physiological pH).  
 
For the formation of silica shell on the cores, two main approaches are followed, both 
of them originally used for producing silica nanoparticles. In the first method, known as 
Stöber process (35),  silica is formed on the surface of the iron oxide cores by 
hydrolysis and condensation of a precursor as tetraethyl orthosilicate (TEOS). In basic 
media TEOS undergoes hydrolysis and polycondensation reactions that results in 
formation of amorphous silica. The method is very versatile, the adjustment of the 
silica shell being possible by varying several parameters: the solvent type (higher 
molecular weights alcohols form larger core- shell nanoparticles), the concentration of 
iron oxide nanoparticles (lower concentrations of iron oxide conduct to bigger 
composites nanoparticles), the concentration of the silica precursor, the concentration 
of ammonia catalyst and the water (36-39). 
 
The synthesis of uniform silica shells, with single core and controlled thickness is still a 
challenge, although the method is relatively simple and a lot of research was and is still 
conducted on core-shell nanoparticles with silica shell. The microemulsion method is 
an alternative to Stöber technique (40, 41). Water-in-oil microemulsion (w/o) or inverse 
microemulsion was extensively studied and used for the production of silica 
nanoparticles with a narrow size distribution (42-47). This route is becoming favored 
for the synthesis of core –shell nanoparticles, the inverse micelles being used as a 
confinement and controlling factor for the growth of the silica shell (48-52).  
 
Due to the condensation reactions that continue during the post synthesis processing, 
the particles produced are strongly necked and aggregated, even though the method has 
the advantage of greatly controlling the thickness of the silica shell. The aggregation 
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and necking result in an increase of the overall size of the particles, decrease in the 
surface area and reduced stability of the particles in colloids.  
 
This thesis is specifically addressing solving the aggregation issue of the particles 
obtained by inverse microemulsion method (Paper I). Well-dispersed, perfectly 
separated (without the presence of interparticle bridging) and single core-shell 
nanoparticles with an excellent control of the shell thickness are obtained and are 
shown to be biocompatible (Paper II). 
 
Specific magnetic properties 
The magnetic nanoparticles and the structures in which the magnetic nanoparticles are 
incorporated have to undergo complex magnetic characterizations in order to assess 
their magnetic properties and the potential applicability in medical areas where these 
features are essential (i.e. MRI). 
 
When the magnetic properties of a material are assessed, the value of magnetic moment 
for the sample is a sum of the magnetic moments of the atoms from the sample. This 
value is influenced by several parameters, some sample dependents: the size of the 
sample and the magnitude of the magnetic ordering, other measurement conditions 
dependent as temperature and applied magnetic field.  
 
The iron atom, due to its four unpaired electrons in 3d orbitals, has a high magnetic 
moment. When iron atoms form crystals, different magnetic behaviors can occur 
(figure 2). 
 
Figure 2. Alignment of individual atomic magnetic moments in different types of 
materials. (53)  
 
 
Paramagnetism 
Ferromagnetism 
Antiferromagnetism 
Ferrimagnetism 
TC 
TC 
TN 
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In the materials with a paramagnetic behavior, the magnetic moments of the atoms are 
randomly aligned, the crystal having a zero net magnetic moment. If this crystal is 
under an external magnetic field, the crystal will have a small net magnetic moment 
due to the alignments of some of the moments. A ferromagnetic crystal has all the 
moments aligned even in the absence of a magnetic field. In a ferrimagnetic crystal, the 
net magnetization is the sum of individual atomic magnetic moments that are arranged 
antiparallel and that have different strength. If the antiparallel moments are equal in 
magnitude, the crystal is antiferromagnetic and the net magnetic moment is zero.  
 
The ordered arrangement of the magnetic moments decreases with the increase in the 
temperature (due to thermal fluctuations of the magnetic moments of the atoms). For 
ferro-, ferri- and antiferromagnetic materials is defined a critical temperature below 
which a spontaneous magnetization is present: Currie temperature (Tc) for ferro- and 
ferrimagnetic materials and Néel temperature (TN) for antiferromagnetic materials.  
 
Large particles and bulk materials have a multidomain structure, with regions of 
uniform magnetization being separated by domain walls (fig 3). 
 
 
Figure 3. Single domain nanoparticles versus multidomain structure of a bulk magnetic 
material (54) 
  
When the particle size of the material decreases the number of the domains decreases 
until it reaches one single domain (below a critical size DC, material dependent). A 
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single domain particle uniformly magnetized has all the spins aligned in the same 
direction that results in very high coercivity (18).  
 
When a ferromagnetic material of magnetization M is subjected to a magnetic field H, a 
magnetization curve with a hysteresis is obtained (Figure 4 (a)). M increases under an 
increasing H till it reaches a maximum value called saturation magnetization Ms. When 
H decreases, the domains do not return to their original orientation, the material having 
a residual magnetization called remnant magnetization MR which can be annulated by 
applying a magnetic field in the opposite direction of the initial field, HC.  
    
Figure 4. Magnetization hysteresis curves of (a) ferromagnetic and (b) 
superparamagnetic materials.  
 
Another important parameter that characterizes the monodomain particles is the 
anisotropy energy. It represents the preference of the magnetization to orient along 
preferential directions in the nanoparticles (relative to the crystallographic directions). 
The axes along which the magnetic energy is minim called easy axes or anisotropy 
directions.  
 
The anisotropy energy is a function of the tilt angle: 
2sinVKE eff             (1) 
Keff is the effective uniaxial magnetocrystaline anisotropy constant, V is the volume of 
the particles and θ is the angle between the magnetization direction and the easy axis. 
The anisotropy energy is dependent on several factors as shape of the crystal, bulk 
magneto crystalline anisotropy and the agglomeration degree that give rise to dipole 
interaction between neighboring particles.  
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For single monodomain particles, the anisotropy energy is comparable with the thermal 
energy: TkE BT                    (2) 
 kB is Boltzmann constant and T is the absolute temperature.  
 
When kBT<<KeffV, the magnetic moment is fixed along the easy axis of the 
magnetisation, thermal energy being too small to overcome the anisotropy barrier. The 
nanoparticles are called then thermally blocked particles with the magnetic moment 
“blocked” along a specific easy axis (crystallographic direction).  
 
When kBT>>KeffV the system behaves paramagnetic with the magnetic moments 
randomly arranged, the thermal energy being high enough to deviate the magnetic 
moment from the easy axis. The atoms are ferromagnetically coupled resulting a 
“super” moment inside of each particle, phenomenon called superparamagnetism (55). 
 
In a magnetic field the superparamagnetic nanoparticles have  no remanent 
magnetisation, no coercivity while maintaining a very high saturation magnetization (8) 
(figure 4(b)).  
Characteristic of superparamagnetic nanoparticles is Néel relaxation time, τN, the time 
necessary for magnetisation to return to equilibrium after perturbation:  
Tk
KV
N
Be0                    (3) 
where τ0 is the characteristic relaxation time (anisotropy energy dependent), kB 
Boltzmann constant, T the absolute temperature.  
 
The equation 3 shows that the Néel relaxation time is dependent on the nanoparticle 
volume and the temperature.  
 
1.3 MAGNETIC NANOCOMPOSITES 
Magnetic nanocomposites are 3D nanostructured materials with 0D structures 
(magnetic nanoparticles) dispersed in a polymeric matrix. They combine the 
properties of the polymeric matrix: lightweight, versatile processing, various 
mechanical properties with the properties of the dispersed inorganic nanoparticles: 
superparamagnetism, ferromagnetism, electron and photon transport, size dependent 
band – gap. Thus, novel materials with advanced new functions and applications can 
be obtained (56). A critical challenge in synthesizing a nanocomposite material is to 
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achieve a uniform dispersion of the nanoparticles in the polymer matrix with minimal 
clustering. The clustering of the inorganic fillers is influenced by particle–particle and 
particle–matrix interactions. It is therefore important to design synthetic and 
processing strategies of the polymeric nanocomposites in which the internal steric 
forces are overcome, and the nanoparticles are prevented from forming larger 
agglomerates. The in situ polymerization and in situ formation of the nanoparticles 
are chemical methods that are an alternative to the physical methods of mixing 
particles in the polymeric melts successfully obtaining transparent nanocomposites 
(56).  
 
For applications where magnetic properties are desired, using nanoparticles with 
magnetic properties is necessary. Metals such as Fe (57), metal alloys as CoPt (58), 
oxides as ferric oxides (59) and ferrites (60) are used as inorganic fillers. The 
polymeric matrix material is chosen depending on the intended application as vinyl 
esters (61) where high mechanical and chemical resistance is required like in car 
industry, or polymethyl methacrylate (PMMA), polystyrene (PS) where transparency 
is needed like in microelectromechanical systems (MEMS):  micro actuators, sensors, 
relays and magneto-optical devices based on the Faraday effect (62).  Paper IV deals 
with synthesis of magnetic nanocomposites. 
 
1.4 BIOMEDICAL APPLICATIONS OF NANOMATERIALS 
Nanomedicine, which sees in the latest years an extensive research effort and 
development, represents the application of nanotechnology in medicine. Drug 
delivery and diagnostics/imaging are the main areas in medicine where 
nanomaterials find applications. 
 
Diagnostic applications. The imaging techniques are used in clinics to detect diseases 
at an early stage, to monitor the effect of therapeutics as well to monitor the evolution 
of the disease during the medical treatment and post therapy phase. 
 
In imaging, contrast refers to the signal differences between adjacent regions and is an 
important parameter that is used for differentiating between different type of tissues and 
between healthy and disease affected tissue. While the contrasting effect X-ray and 
computer tomography (CT) is a direct contrast due to the electron density difference in 
Magnetic Resonance Imaging (MRI), the contrast enhancement is an indirect contrast 
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resulting from the interaction between the contrast agent and the neighboring water 
protons.  
 
MRI, among other non-invasive imaging techniques such as computed tomography 
(CT), positron emission tomography (PET), ultrasound (US) and optical imaging (OI), 
is one of the most used methods in research as well as in clinics due to its capability of 
imaging the soft tissue structures (40). Primarily used for producing anatomical images, 
MRI gives also information on the physiochemistry of the tissue, flow, diffusion and 
motion (63). 
 
The fundamental principle of MRI is that unpaired nuclear spins (mainly from 
hydrogen atoms in water: 70% to 90% of most tissues and organic compounds) align 
themselves when exposed to a magnetic field. A temporary radiofrequency pulse 
change the alignment of the spins, and their return to baseline (relaxation) is recorded 
as a modification in electromagnetic flux. Protons from different tissues react 
differently giving a picture of anatomical structures (64). Two independent processes, 
longitudinal (or spin-lattice) relaxation (T1-recovery)(fig. 5a) and transverse (or spin-
spin) relaxation (T2-decay)(fig. 5b), can be monitored to generate an MR image.  
 
 
  
 
Figure 5. T1 recovery(a) and T2 decay(b)(65) 
 
MR imaging is considered to be highly sensitive (to show pathological changes in a 
tissue) but not so specific (i.e. different pathologies have similar appearances) (65). The 
development of chemically synthesized contrast agents has helped MRI become a 
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powerful tool for clinical diagnosis and biomedical research (66). Contrast agents help  
to improve the specificity by inducing a change in the behavior of the surrounding 
tissue (affecting the behavior of protons in their proximity), better tissue 
characterization and a reduction in image artifacts (67, 68). They enhance the image 
contrast between normal and diseased tissue and indicate the status of organ function or 
blood flow after administration by increasing the relaxation rates of water protons in 
tissue in which the agent accumulates (69). 
 
Apart from general requirements as: tolerance, safety, toxicity, stability, osmolality, 
biodistribution, elimination and metabolism (68), contrast agents have to possess 
specific prerequisites as adequate relaxivity and susceptibility.  
 
Currently available MRI contrast agents can be categorized into two broad groups: T1-
agents and T2-agents. T1-agents generally increase the longitudinal (or spin-lattice) 
relaxation rates (1/T1) of water protons in tissue more than the transverse (or spin-spin) 
relaxation rates (1/T2).  
 
Soluble paramagnetic agents as gadolinium and manganese chelates are having 
dominantly T1-lowering effect with an increase in signal intensity on T1 weighted 
images (positive contrast agents). Nanoparticles that can carry a large number of 
paramagnetic T1 contrast molecules will produce a strong T1 contrast signal. Platforms 
as silica (70) and nanotubes (71) have been successfully used but they have sizes over 
100 nm and low blood half time circulation. MnO nanoparticles are in the development 
stage as new T1-MRI contrast agents for brain, liver and kidney imaging (72).   
 
The superparamagnetic iron oxide nanoparticles (SPION) are T2-agents increasing the 
1/ T2 of tissue selectively leading to decreases in signal intensity on T2 weighted images 
(negative contrast agents). The ability of SPIONs to perform as MR imaging contrast 
agents  is actively investigated in the last 20 years (73). They are classified based on 
their size, which is affecting the biological distribution, as follows: (i) micrometer sized 
paramagnetic iron oxide (MPIO), ii) superparamagnetic iron oxide (SPIO) and iii) 
ultrasmall superparamagnetic iron oxide (USPIO). Commercial SPION as Ferridex®, 
Combidex®, Resovist®, AMI-228/Ferumoxytrol®) are dextran or other carbohydrate 
coated or citrate-stabilized particles (VSOP-C184) (74, 75) but SPION with other 
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coating materials (polymers, metals (gold, silver), silica) are either in the development 
phase or in different phases of the preclinical study.  
 
When MRI contrast agents are coupled with molecular probes that recognize certain 
tissue signatures, then the visualization has an enhanced specificity to certain 
modification in the targeted tissue (73). Multifunctional nanoparticles find application 
in diagnosing some of the most prevalent diseases in humanity.   
 
The multimodal specific imaging of cardiovascular diseases is one of the important 
impact applications. Multifunctional magnetic nanoparticles are proposed as MRI 
contrast agents for several clinical cardiovascular applications as myocardial injuries, 
and atherosclerosis.  The increased uptake of SPION by the macrophages (hallmark 
cells in atherogenesis) and further functionalization of SPION with adhesion molecule 
(V-CAM) – target for endothelial and macrophage cells– will improve the early 
diagnosis and decrease the morbidity and mortality associated with atherosclerosis (73, 
74).  
 
Cancer imaging is another extremely important application of multifunctional magnetic 
nanoparticles as this disease is the second worldwide death cause. The early detection 
of the disease associated with early treatment increase the curability chances with 
dramatic social and economic impact. The current resolution limit of 2-3 mm (for liver 
tumors) and lymph metastases of 5-10 mm can be decreased significantly by active 
targeting (antigen – antibody reaction) of a specific marker expressed on the tumor 
cells or SPION labeling with a precursor lesions specific antigen (74). The drug loading 
of the targeted nanoparticles adds to the sensitive MRI agent particles the function of 
controlled drug carrier. Covalently bonded methotrexate on the magnetic nanoparticles 
and pH induced release of the antitumoral agent into the specific tumoral cells allowed 
MRI localizing the nanoparticles before and after the drug release (76). 
 
If a cell can be sufficiently loaded with magnetic nanoparticles, cell tracking by MRI is 
another possible application with the resolution near to the size of the cell. Localizing 
pre-loaded cells with functionalized magnetic nanoparticles after transplantation or 
transfusion, apoptosis detection or monitoring enzymatic activities are just few of the 
new highly specialized multimodal MRI applications in medicine(8, 73). 
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Drug delivery. Most of the drugs in use today in medical treatments need periodical, 
frequent administration in order to obtain a long-term effect. Drug targeting/delivering 
by nanoparticles or nanocapsules reduces dosage and minimizes side effects, ensures 
the pharmaceutical effects, protects drugs against degradation and enhances drug 
stability. Many types of drug delivery nanosystems have been developed based on 
biocompatible materials as polymer nanoparticles (77-79), lipid-based nanoparticles 
(80-82), inorganic materials-based nanoparticles (83-85) and nanogels (86-88). More 
advanced systems can either respond to some physiological changes in the body (pH, 
temperature) – self regulated systems - or the drug release can be enhanced ad 
necesitum by an exterior triggering system (magnetic field or ultrasounds) (89-91).  
Nanoparticles that combine multiple imaging capabilities with delivering an active 
substance are the next generation “theranostic”. Magnetic nanoparticles are obvious 
candidates for designing theranostic agents. Using dextran coated SPIONs of 10 nm 
loaded with Alexa Fluor 750 and a potent photosensitizer (92) enhanced photodynamic 
therapy properties can be achieved. Gold-coated iron oxide nanoparticles can be used 
for combined molecular speciﬁc MRI/optical imaging and photothermal therapy of 
cancer cells (93).  
 
1.5 SAFETY ASSESSMENT OF NANOMATERIALS 
Safety assessment is an interdisciplinary approach that is trying to understand and 
measure the hazard and the exposure to a certain factor with the goal of assessing the 
risk associated with it.  
 
Factors that must be addressed in assessing a risk associated with a substance or 
nanoparticles include dose, exposure routes, and biokinetics. Especially when 
performing safety assessment for nanoparticles a thorough physical chemical 
characterization is important as the nanoparticles characteristic is tightly associated 
with their effects (94).  
 
1.5.1 Nanotoxicology – Overview 
Toxicology is the study of the adverse effects of physical or chemical agents on living 
organisms. The principle that the risk posed by a substance is proportional to the 
potential to cause a hazard and with the amount of substance that the biological system 
is exposed to is one of the basic principles in toxicology(95). Nanotoxicology that is the 
study of the effect of nanoparticles on living organisms (96). This multidisciplinary 
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science integrates the understanding on the materials characteristics of the nanoparticles 
with its potential toxicity. Notably, exposure assessment is also needed for risk 
assessment of nanomaterials. 
 
One characteristic of the nanostructure materials is their small size and the properties 
associated with it that might render them toxicity compared to the bulk form of the 
same material. In this light, it has to be emphasized that the toxicity is associated to a 
certain entity characterized by size, chemical composition, shape, surface charge etc. It 
is therefore essential to not discuss about nanoparticles in general terms but to identify 
them in the context of their possible biological interactions.  
 
Dose. The toxicity of nanomaterials is strongly associated with the notion of dose and 
the way this is expressed i.e. mass versus particles number versus surface area. 1mg of 
10 µm spherical carbon  nanoparticles contains 10
12
 nanoparticles with a total surface 
area of 270 m
2
 whereas 1mg of 10 nm of the same materials contains 10
21
 nanoparticles 
with a total surface area of 270 000 m
2 
(97).  At least two  ways of expressing the dose 
allows a better understanding of the observed effects of nanoparticles (98).  
Furthermore, due to surface binding of molecules in biological media and eventual 
change in the agglomeration state of the nanomaterials, the effective surface area is 
another parameter that  has to be considered in expressing the dose of a material (99).  
 
Exposure route and biokinetics. The toxicity of nanoparticles to a biological system 
is highly dependent on which organ or cell types are exposed primarily. The 
toxicokinetics: uptake, transport, metabolism, accumulation in different organs and the 
final elimination of the nanoparticles from the organism is equally important when 
discussing about the nanotoxicity. There are various ways through which the 
nanoparticles are potentially encountering  the biological systems: inhalation via the 
respiratory system, via dermic or mucosal membranes, enteral via gastrointestinal tract 
and parenteral via injection in different body tissues (1). The latter is certainly of great 
relevance in medicine. 
 
For engineered nanomaterials (nanoparticles, nanofibers, nanotubes) that are 
formulated as powders, in a scenario of occupational exposure, lung is a primary organ 
for exposure. Exposure of rats to TiO2 particles of various sizes (12 nm-250 nm) 
induced a size dependent acute inflammatory response followed by a remise of the 
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response to control levels 64 weeks post exposure. The smaller particles accumulated 
within the lung longer time than the bigger particles that were translocated in the 
interstitium due to a faster the uptake by the alveolar macrophages (100). Translocation 
of nanoparticles post inhalation to other organs like central nervous system via 
olfactory neurons is of particular concern (101) even though the translocation is highly 
dependent on the type of nanoparticle, size surface charge and the bio corona particles 
might acquire in contact with the nasotracheal mucus (94). The fiber – like shape of 
carbon nanotubes raised concerns over respiratory exposure to this nanomaterials and 
the possible asbestos like behavior with the induction of mesothelioma (102). Studies 
showed that even if the translocation to subpleural area of multiwall carbon nanotubes 
is possible (103) this might be dependent on batch to batch or provider (104) variation 
of the characteristics of the materials. Furthermore, possible enzymatic degradation of 
the single wall carbon nanotube (105) might be reducing the inflammatory process post 
exposure to these materials. 
 
Healthy skin is an effective barrier for the entry of nanoparticles but in special 
conditions as sunburn or diseases the translocation of nanoparticles (106) via 
Langerhans cells to lymph nodes and to blood is possible. The exposure to TiO2 or 
ZnO2 nanoparticles via sun creams can result in translocation of the nanoparticles via 
the more permeable barrier of sunburned skin (107).  
 
A wide variety of nanoparticles are used in food industry from Ag nanoparticles in 
food packaging, amorphous SiO2 and PS  as food additive, titanium dioxide (TiO2), 
gold (Au), platinum (Pt) and zinc oxide (ZnO) nanoparticles in cosmetics, especially 
sunscreens and toothpastes (108). Exposure to 50 nm polystyrene carboxylated 
nanoparticles in chicken induced inhibition of iron transport after acute exposure. A 
chronic exposure induced morphological changes in the intestinal villi to increase the 
surface area available for iron absorption. Also systemic effects like an increase of the 
coagulation time suggests also lipophilic vitamins deficiencies (vitamins A, D, E, K) 
(109).  
 
In different diagnostic or therapeutic formulations, the nanoparticles can be exposed 
to blood via i.v. injection. Within the biological fluid the nanoparticles will rapidly 
acquire a corona of bio – molecules that will influence the biokinetics and the 
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interactions between the nanoparticles and the biological systems. For a more detail 
description of biocorona see 1.6. 
 
1.5.2 Interaction of nanomaterials with immune system 
The primary function of the immune system is to protect against foreign material 
(micro – organism, particles) to enter the organism. The innate immunity and the 
adaptive immunity are part of the immune system to protect against foreign intruders 
(Figure 6) (110).  
 
Macrophages are professional phagocytic cells and important for removal of cell debris 
and foreign material. Dendritic cells (DCs) are antigen – presenting cells and 
orchestrate adaptive immune responses.  
 
 
 
Figure 6. Innate and adaptive immune system (110) 
 
Upon contact with blood and formation of bio – corona, nanoparticles might interact 
with red blood cells and thrombocytes involved in blood coagulation. In vitro exposure 
to human whole blood to gold nanoparticles (30 nm and 50 nm) did not cause delays in 
coagulation time or platelet aggregation (111). Studies on polyvinyl chloride resin 
particles (112) showed the effect of polyethylene glycol (PEG) coating as after the 
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coating the increase of the coagulation time, platelet aggregation in the presence of  
polyvinyl chloride resin were not observed.  
 
The biochemical cascade known as complement system has as function the removal of 
the pathogens. The complement can be activated by the physical and chemical 
characteristics of the nanoparticles: size, shape, surface charge as well as composition 
(113, 114).  Strategies like coating with PEG (115) or with polysaccharides (116) to 
avoid the complement activation by the nanoparticles showed that the complement 
activation is highly sensitive not only to the coating molecules but also on their density 
on the surface and the induced conformational changes.  
 
The production of specific antibody (antigenicity) upon contact with nanoparticles as 
well as the production of cytokines is another response from the immune system. B 
cells production of antibodies can be in response to either nanoparticles themselves or 
to the functional groups or biomolecules attached on the surface (117).  The size and 
the surface properties of the nanoparticles are important factors in determining the type 
of immune response (118, 119). In the event of inflammation, the immune cells are 
activated and secretion of cytokines (signaling molecules) is triggered. The positively 
(120) and neutral charged particles seem to trigger more the cytokine production 
compared to positively charged particles (ref). An increased immune response to 
nanoparticles as PMMA nanoparticles (121) or 200 nm amylopectin and  maltodextrin 
nanoparticles (122) compared to the aluminum phosphate adjuvant render them 
applicable as adjuvant in vaccine strategies.  
 
There is an emerging understanding that most of the toxicity effects exhibited by the 
nanoparticles as well as the interactions with the immune system are due to the 
presence of the biological corona on the surface of the nanoparticles.  
 
1.6 NANO – BIO INTERACTIONS 
Nanoparticles are endowed with a synthetic identity which comprises of a specific 
morphology (size and shape), chemical composition as well as surface properties 
(chemical reactivity, charge, roughness) (123). But will the cell “see” any of these 
intrinsic features? Or rather the cell will “sense” a completely new biological identity 
(with a new size and shape – determined by the attachment of the biomolecular corona 
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and possible induced/decreased agglomeration, a new surface charge) that will 
determine the possible interactions with the biological systems (124)? 
 
1.6.1 Role of bio – corona 
When nanoparticles, either accidentally or as part of different formulations for 
biomedical applications, come in contact with the nanoparticles enter in contact with 
physiological media, they encounter a complex environment that contains a huge 
variety of molecules with different functions: proteins, carbohydrates, nucleic acids and 
lipids (125). The biomolecular corona formation is a primary phenomenon at the 
interface between biological liquids and nanoparticles surface that will influence how 
the particles will initiate various reactions from the biological system and consequently 
will affect the fate of the particles (126) (127).  
 
 
Figure 7.  Schematic drawing of the structure of protein–nanoparticle: an outer layer of 
proteins (full red arrows) and a hard slowly exchanging corona of proteins (right) (124) 
 
Studies on different types of nanoparticles reflect the biomolecular corona formation as 
a dynamic phenomenon. The Vroman effect (128-130) seems to dominate the dynamic 
of the formation of the corona on the nanoparticles surface, resulting in a competitive 
adsorption to a relatively small numbers of adsorption sites.  The molecules with a 
higher mobility and abundance will absorb in initial stages being replaced later by 
molecules with higher affinity for a specific surface. The adsorption of biomolecules is 
driven by the surface dependent properties as surface charge, 
hydrophibicity/hydrophilicity (131). The size of the nanoparticles plays an important 
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role as the surface area available for interaction with the media is a limiting factor 
(132). It is generally accepted that immediately after the contact with the biological 
media, an initial corona is formed by the loosely bound low affinity proteins. A 
prolonged incubation allows the formation of denser, irreversibly attached, “hard” 
corona from high adsorption affinity proteins (133, 134) and a satellite “soft” corona 
that encounters intensive exchanges with the surrounding media (135). The “hard” 
corona is formed due to the direct interaction of the proteins with the surface of the 
nanoparticles while the protein-protein interactions dominate the exchanges interactions 
of the “soft” corona with the “hard” corona (124). The time scale of the process 
probably is very short with a stable corona formation after as short as 30 seconds (136). 
Relevant  for in vivo fate of long circulating nanoparticles might be the “hard” protein 
corona that is strongly attached to the surface of nanoparticles and resist to events as 
translocations through biological membranes (137). Furthermore, changes in the “hard” 
corona might occur when the particles are transferred to another biological 
compartment with a different biomolecular profile (137).  
 
Regardless the way the nanoparticles enter the body and the biological identity they 
acquire upon interaction with various biological media they will finally interact with 
the cells membrane, and they will have a degree of impact on the cellular function. In 
this thesis, the impact of nanoparticles with/without a corona of plasma proteins is 
investigated (Paper III).  
 
1.6.2 Safety by design 
Going back to the chemistry lab and trying to design a “perfect” nanoparticle one 
would have to think how the physical and chemical parameters affect their 
performances when applications in nanomedicine are envisioned.  Part of the designing 
process of a “safe” nanoparticle the formation of the protein corona and its possible in 
vitro and in vivo implications needs to be addressed.  
 
Size. The size of the nanoparticles is not important just because they are in same 
dimensions range with biological molecules but also because of the increased surface 
area and increased constituents atoms exposed to the surface. Regarding protein 
adsorption size might be important as smaller sizes (under 30 nm) might induce a 
reduction of the protein adsorption (138) due to space restriction and consequent steric 
hindrance. An increase in size is reflected by increasing protein coverage (134, 139). 
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Furthermore, the possible induced agglomeration of the nanoparticles by the protein 
coating might change the effective surface area and might induce undesired in vivo 
effects as infarctisation of small capillary.  
 
Surface properties. The interaction between the particles and the cells surface or 
biological membranes (negatively charged) might be influenced by the zeta potential of 
the nanoparticles (140). Additionally, the surface charge seems to play an important 
role in biocorona formation, with more proteins binding to more charged particles (141) 
than the neutrally changed surfaces (142). An increase in the protein adsorption to the 
nanoparticles surfaces is observed on the more hydrophobic nanoparticles as compared 
to the hydrophilic nanoparticles (143). The formation of a protein corona might trigger 
opsonisation and eventual fast clearance from the blood stream, lowering the chance 
that the particles will reach the target sites/cells to achieve their goal. Furthermore, 
activation of the complement cascade and coagulation cascade will trigger immune and 
systemic undesired responses. Consequently strategies that would minimize protein 
adhesion to the surface of the nanoparticles has to be included in the design. 
Antifouling coating with long chain polymers like PEG (127) or polysaccharides (144) 
induce a reduction of protein adsorption and consequently a reduce interaction with 
immune system.  
 
Particle chemistry and crystalline structure. Chemically stable nanoparticles are 
preferred for most applications. The release of ions in liquid media (as ZnO 
nanoparticles) with potential toxic effects (140), or the surface oxidation of particles 
(145) in different media might trigger different toxic and immune effects. For some 
materials, the toxicity depends on its type of crystalline form (146): 200 nm 
nanoparticles TiO2 rutile induced oxidative DNA damage while the effect was not 
observed for the same size nanoparticles but anatase crystalline structure.  
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2 AIMS OF THE STUDY 
 
The aims of the whole study are divided chronologically in: 
 
 To synthesize engineered core-shell nanoparticles with single iron oxide core 
and finely tunable silica shell with a narrow size distribution as contrast 
agents for MRI. 
 
 To investigate the effect of SPIONs with different surface coatings (silica 
versus dextran) and different sizes on immune cells (human primary 
macrophages and human primary dendritic cells): on in vitro biocompatibility 
and cellular internalization. 
 
 To determine how the surface of SPIONs (silica versus dextran) affects the 
composition of the corona of human plasma proteins and the subsequent  in 
vitro behavior of the nanoparticles. 
 
 To synthesize homogeneous, transparent 3D nanostructures with iron oxide 
nanoparticles dispersed in PMMA matrix via in-situ polymerization for 
magneto-optic applications.  
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3 MATERIALS AND METHODS 
 
Detailed description of the materials and techniques used in our studies can be found in 
the publications and manuscripts included in the thesis.  The sections below provide a 
summary of the methods and their basic principles. 
 
3.1 SYNTHESIS 
3.1.1 Magnetic nanoparticles 
SPION and thermally blocked nanoparticles were prepared by high temperature 
decomposition of an iron precursor: iron oleate - Paper I, Paper III and Paper IV or iron 
oxyhydroxide - Paper II. Both syntheses are high temperature decomposition synthesis 
in a high boiling temperature organic solvent (oleic acid) that enables accurate control 
of the size of the obtained iron oxide nanoparticles. The resulting particles have a 
surface capping of oleic acid, readily dispersible in organic solvents. Even though the 
method that is using iron oleate as precursor (31) is a two steps method, the nucleation 
and growth is homogeneous as the precursor is a solution. Using iron oxyhydroxide 
(FeO(OH)) as precursor (33, 34) is a one – pot method in which  the dissolution of the 
precursor, formation of iron oleate complex and thermal decomposition at elevated 
temperatures is taking place successively by heating up the mixture. In this method, the 
separation of the nucleation and growth process from the formation of iron oleate 
precursor is not so effective and consequently, obtaining monodispersed iron oxide 
nanoparticles is difficult to control.   
 
3.1.2 Core – shell nanoparticles (CSNPs) 
The SPION obtained by both methods were subsequently coated with silica shell by the 
inverse microemulsion method in a Triton X100/hexanol/water/cyclohexane system 
(Figure 8). The microemulsion system is recognized as an effective way of controlling 
the size of the particles. Even though the obtained particles are highly monodispersed, 
the unreacted precursor creates aggregation during the destabilization of the 
microemulsion and collection of the particles. The introduction of two supplementary 
steps in the post synthesis process: (i) pH adjustment to approximately 2 and (ii) 
successive cycles of liquid N2 cooling, improved dramatically the quality of the 
obtained core shell nanoparticles. (Paper I, Paper II) 
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Figure 8. Schematic of the CSNPs synthesis by inverse microemulsion and Stöber 
method 
 
The size of the water phase droplets is the limiting factor of the growth of the 
particles in the inverse microemulsion system. The increase of the particles size over 
a certain value will have as consequence a decreased stability of the microemulsion. 
This fact will have as effect a broadening of the size distribution of the resulting 
particles. Consequently, the seeded particle growth using Stöber method (147) 
(Figure 8) was utilised for obtaining core-shell nanoparticles with larger size (Paper 
II, Paper III). As seeds CSNPs with average diameter of ~30 nm were used which 
were obtained through silica coating in inverse microemulsion. The thickness of the 
silica layer is controlled by the amount of the silica precursor added, the other 
variables (the seeds concentration, water to alcohol ratio, quantity of ammonia, 
reaction time) being maintained constant.  
 
3.1.3 Magnetic nanocomposites 
Several chemical approaches have been developed to prepare nanocomposites of 
nanoparticles and copolymers. In the two step approach used in Paper IV the 
nanoparticles are prepared first  followed by chemical polymerization of the polymer 
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around the particles (148, 149). The use of organic dispersible nanoparticles and 
sonication as method for dispersing the fillers in the monomer matrix results in 
homogeneous nanocomposites.  
 
3.2 PHYSICAL AND CHEMICAL CHARACTERISATION METHODS 
The fabricated materials (SPIONs cores and CSNPs) as well as the commercial dextran 
coated SPIONs (nanomag®-D-spio) were analyzed at various stages of the synthetic 
process and during the biocompatibility assessments using a large variety of techniques 
described as follow.  
 
Atomic absorption spectroscopy (AAS) and Inductively Coupled Plasma (ICP). 
The amount of iron oxide nanoparticles in cyclohexane suspension and of iron oxide 
core – silica shell composites in the final water suspension was measured by AAS 
(Paper I) and ICP (Paper II, Paper III, Paper IV). 
 
The basics principle of both techniques relies on the fact that atoms emit characteristics 
electromagnetic radiation (hν) as they relax from an excited state to their ground state. 
The main differences between these two techniques are the source of energy used for 
the excitation of atoms: flame (1500–2500 °K) and plasma (4000–8000 °K) and related 
to this is the ionization efficiency and the detection limit (ppm – AAS, ppb – ICP). 
Another important advantage is the possibility to analyses multiple elements in one run 
for ICP whereas AAS measurements are limited to one element at a time. 
 
The sample preparation for these techniques consists of complete removal of the 
sample from its original matrix in order to minimize interferences which practically 
means digesting the sample with a strong acid.  Both techniques require the use of 
standard solutions for calibration curves in order to perform quantitative analysis.  
 
Electron Microscopy. In any type of microscopy, the image is formed as a result of the 
interaction of the incident particles with the samples. In electron microscopy, when the 
particles (electrons) hit the sample, different interactions can occur. These interactions 
and the generated signals are the basis of the various imaging and spectroscopy 
methods that can be utilized in electron microscopy. From the incident electron beam 
only a small part is passing through the sample with the energy unchanged. Most of the 
incident electrons will have their initial energy reduced as a result of inelastic 
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interactions (X-rays, Auger electrons, secondary electrons, plasmons, phonons, UV 
quanta or cathodoluminescence) (Figure 9). A small part of the electrons will have their 
energy preserved but their trajectory will be modified as a result of elastic interaction 
with the sample. 
 
Figure 9. Scheme of electron-matter interactions arising from the impact of an electron 
beam onto a specimen. 
 
Transmission electron microscope (TEM). In TEM the transmitted electrons through 
the thin sample are used to form a map of local densities and diffraction information 
(ED) when crystalline samples are analyzed. The morphology, size and size distribution 
study of the iron oxide cores and iron oxide core – silica shell nanoparticles were 
investigated with transmission electron microscope (TEM).  
 
Scanning electron microscopy (SEM). The possibilities of analyzing just very thin 
specimens on a very small area are important limitations of the TEM. These constraints 
were the incentives for developing electrons microscopes that can analyse bulk (thick) 
samples on a much larger area - SEM. In SEM, as in TEM, the dual character of 
electrons (charged particles and wave) is exploited to image the sample. The beam of 
primary electrons is scanned across the specimen simultaneously in two perpendicular 
directions covering a square/rectangular area of the sample (raster). Collecting the 
secondary electrons from each point of the sample an image can be formed.  
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Fourier Transform Infrared Spectroscopy (FTIR). The study of the surface of the 
particles is performed using FTIR analysis.  
 
FTIR is based on the fact that most molecules absorb light in the infra-red region of the 
electromagnetic spectrum (0.8 μm to 1 mm wavelength), this absorption corresponding 
specifically to the bonds existing in the molecule. The sample is irradiated with a broad 
spectrum of IR light and the absorbance at particular frequencies is plotted after the 
data is treated with a Fourier transformation. The resulting spectrum is a fingerprint of a 
sample with absorption peaks that correspond to the frequencies of vibrations between 
the bonds of the atoms in the molecule. The analysis of the samples is done either in 
solid (dry) or colloidal form. Due to the Attenuated Total Reflectance (ATR) crystal in 
the structure of the FTIR, no sample preparation is required (apart from evaporating the 
solvent to obtain the dry powder when the study is done in dry form).  
 
X-ray powder diffraction (XRD). When radiation hits a sample, it is either scattered 
(in an elastic manner or inelastic) or absorbed. When the scattering is entirely elastic, 
the energy of the primary radiation remains unchanged, no energy being lost. The 
regular arrangement of the atoms in a crystalline material interacts elastically with the 
radiation that has the wavelength comparable with the interatomic distance. The 
principle of XRD powder diffraction is based on the elastic interaction of the X ray 
radiation with samples. X-rays are produced with wavelengths matching the unit cell 
dimensions of crystals (10
−10
 m). The result is a diffraction spectrum in which the 
intensity of the scattered radiation is plotted as a function of the scattering angle. The 
diffraction angles and the diffraction intensities are a function of the crystal structure.  
 
The diffraction pattern obtained by XRD powder diffraction can help in identifying the 
phase composition of a sample, in calculating the unit cell lattice parameters and the 
crystallites sizes but can also give information about residual strains (macro or micro-
strains).  
 
Dynamic light scattering (DLS).  When particles are dispersed in a liquid medium 
they undergo Brownian which causes the fluctuations of the local concentration of the 
particles, resulting in local inhomogeneity of the refractive index. DLS is determining 
the velocity distribution of particles movement by measuring dynamic fluctuations of 
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intensity of scattered light. With the assumption that the particles are spherical and 
non-interacting, the mean radius is obtained from the Stokes-Einstein equation 
  
    
    
   (4) 
where R is the hydrodynamic radius, k B  is the Boltzmann constant, T  the 
temperature, and η  the shear viscosity of the solvent.  
 
The sample temperature is important, as is directly proportional to the radius value but 
also because viscosity of the solvent is directly dependent to the temperature.  Most 
importantly, the particle size determined by dynamic light scattering is the 
hydrodynamic size, which is the size of a spherical particle that would have a diffusion 
coefficient equal to that of our particles. 
 
Zeta potential measurements. The development of a net charge at the particle surface 
affects the distribution of ions in the surrounding interfacial region, resulting in an 
increased concentration of counter ions (ions of opposite charge to that of the particle) 
close to the surface. Thus an electrical double layer exists around each particle. The 
liquid layer surrounding the particle has an inner region, called the Stern layer, where 
the ions are strongly bound and an outer, diffuse, region where they are less firmly 
attached. Within the diffuse layer there is a notional boundary inside which the ions and 
particles form a stable entity which will move together with the particles. The potential 
that exists at this boundary is known as the Zeta potential. When an electric field is 
applied across an electrolyte, charged particles suspended in the electrolyte are attracted 
towards the electrode of opposite charge. By determining the Electrophoretic Mobility 
it is possible to calculate the zeta potential of particle.  
 
Termogravimetric analysis (TGA) and Differential scanning calorimetry 
(DSC).  Both techniques are thermal analysis studying the change in properties of the 
materials with temperature. DSC is thermoanalytical technique in which the difference 
in the amount of heat required to increase the temperature of a sample and reference is 
measured as a function of temperature. The basic principle of the techniques is that the 
physical transformation of a sample is reflected in the heat exchange necessary to 
maintain the sample at the same temperature as the reference. It can detect exothermic 
and endothermic processes but also more subtle processes as glass transitions. TGA 
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determines changes in weight of the sample in relation to a temperature program in a 
controlled atmosphere.  
 
Ultraviolet – visible spectroscopy (UV–Vis). Ultraviolet and visible (UV-Vis) 
absorption spectroscopy is the measurement of the attenuation of a beam of light after it 
passes through a sample. Ultraviolet and visible light are energetic enough to promote 
outer electrons to higher energy levels. UV-Vis spectroscopy is usually applied to 
molecules or inorganic complexes, as well as nanomaterials having absorption in this 
wavelength region.  
 
3.3 MAGNETIC CHARACTERISATION METHODS 
 
Vibrating sample magnetometer (VSM). VSM uses an induction principle, and is 
widely used for characterizing the magnetic properties of materials.  If a sample of any 
material vibrates with sinusoidal motions in a uniform magnetic field a sinusoidal 
electrical signal (a current or voltage) will be induced in a sensing coil. The electrical 
signal has the same frequency as the vibration frequency of the sample and its 
amplitude is proportional to the magnetic moment. VSM measures permanent moments 
and hysteresis curves of materials. The fitting of the profiles gives several parameters 
as the crystal radius (r) and the specific magnetization (MS). 
 
Magnetic resonance (MR) relaxometry measurements.  The fundamental principle 
of MR relaxometry is identical with the MRI principle (1.4.).   The ability of the agent 
to reduce the T1- and T2- relaxation times are respectively described by the R1 (1/ T1) 
and R2 (1/ T2) relaxation values of the agent and is defined by: 
CrRR 2,12,1
0
2,1                 (5) 
where R1,2 (unit s
−1
) is the respective T1 or T2 proton relaxation rate in the presence of 
the contrast agent, R°1,2  are the relaxation rates in the absence of contrast agent and C 
is the contrast agent concentration (unit mM). The constant of proportionality r1,2 (unit 
s
−1
 mM
−1
) is called relaxivity and is a measure of the increase in the relaxation rate of 
protons per unit concentration of contrast medium (150). 
 
Alternating gradient magnetometer (AGM). AGM measures the magnetic moment 
of a sample by measuring the force on a magnetic dipole by a magnetic field gradient. 
It is a very sensitive method, a factor of 10
2 
more sensitive than VSM. The sample’s 
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size and mass necessary for measurements in AGM are less than in VSM, but the 
measurements are limited to solid samples (151). 
 
Faraday rotation (FR) measurements.  Faraday rotation is a magneto-
optical phenomenon that causes a rotation of the plane of polarization, rotation that is 
linearly proportional to the component of the magnetic field in the direction of 
propagation. Consequently, Faraday rotation is an important property that couples the 
optical and the magnetic behavior of a material. The magnitude of this effect depends 
on the sample magnetization, the wavelength of light used and the length of the sample 
crossed by the light. Materials that have a high FR effect find applications in optical 
telecommunications and other laser applications (152). 
 
3.4 CELL ISOLATION AND CULTURE 
Density is a basic material characteristic defined as mass per unit volume. Blood is a 
liquid tissue composed of approximately 55% fluid plasma and 45% cells. The average 
density of whole blood for a human is about 1060 kg/M
3
. The  density of blood plasma 
is approximately 1025 kg/m
3
 and the density of blood cells circulating in the blood is 
approximately 1125 kg/m
3
. Centrifugation is applied to the whole blood in order to 
separate the different components: erythrocytes, buffy coat (containing 90% of the 
leukocytes from the whole blood and 70-90 x10
9 
platelets) and plasma. In order to 
separate agranulocytes (lymphocytes and monocytes) from the granulocytes 
(neutrophils, basophils and eosinophils) a density gradient centrifugation is applied 
using as sedimentation medium (Lymphoprep or Ficoll-Pacque). Further selection of 
the monocytes from the leucocytes population is performed based on their differential 
expression of Cluster of differentiation 14 (CD14) proteins on their membrane. 
 
3.4.1 Primary dendritic cells 
Dendritic cells (DC) are antigen-presenting cells (APCs) which play a critical role in 
the regulation of the adaptive immune response. One approach to generate DC is by 
culturing CD14+ monocyte-enriched peripheral blood mononuclear cell  (PBMC) in 
the presence of Granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-
4 (153). An additional 3 days “maturation culture” step in the presence of GM-CSF 
and IL-4 is necessary to generate fully mature dendritic cells. Cluster 
of Differentiation 1a (CD1a), complement component 3 receptor 4 subunit (CD11c), 
CD14 and Cluster of Differentiation 83 (CD83) are all surface proteins found in the 
 32 
dendritic cells membranes and markers for the successful in vitro differentiation of 
this type of cells from monocytes (154).  
 
3.4.2 Primary macrophages 
Macrophages are phagocytic cells with function in both non-specific defense (innate 
immunity) as well as help initiate specific defense mechanisms (adaptive immunity) of 
vertebrate animals. The monocytes differentiate in vitro into macrophages by 
culturing in medium containing macrophage colony-stimulating factor (M-CSF) that 
induces differentiation of the monocytes into macrophages (155). CD14, CD68 and/or 
mouse F4/80 or human epidermal growth factor module-containing mucin-like receptor 
1 (EMR1) are widely used as macrophage-specific markers (156).  
 
3.5 CELLULAR TOXICITY ASSESSMENT 
3.5.1 Limulus Amebocyte Lysate (LAL) test 
LAL test detects and measures bacterial endotoxins as Lipopolysaccharides (LPS), 
found in the outer membrane of Gram-negative bacteria.  LPS is an endotoxin that 
induces a strong response from normal animal immune systems.  Furthermore, LPS 
promotes the secretion of pro-inflammatory cytokines in many cell type by binding  
the CD14/TLR4/MD2 receptor complex. Consequently is extremely important that all 
the nanoparticles are tested for LPS contamination before undergoing any type of 
biocompatibility tests (157).  The method used in Paper II and Paper III is an end – 
point chromogenic assay, monitoring the appearance of yellow colour, which is directly 
related to endotoxin concentration in the sample. Endotoxin levels in unknown samples 
are determined by comparison to a standard curve.  
 
3.5.2 MTT test 
To test the mitochondrial activity of the macrophages as a measure of cell viability after 
exposure to nanoparticles, MTT is a common method used. This is a colorimetric assay 
that measures the reduction of yellow 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) by mitochondrial succinate dehydrogenase. The MTT 
enters the cells and passes into the mitochondria where it is reduced to an insoluble, 
colored (dark purple) formazan product. The cells are then treated with an organic 
solvent and the formazan product is released. Since reduction of MTT can only occur in 
metabolically active cells the level of activity is a measure of the viability of the cells 
(158). The assay is convenient as it can be adapted to a 96 – well plate format.  
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3.5.3 Trypan blue exclusion 
Trypan blue (called because it can kill trypanosomes) is derived from toluidine. Live 
cells possess intact cell membranes that exclude certain dyes, such as trypan blue, 
Eosin, or propidium, while the membrane of the death cells is permeable to these 
substances (blue cytoplasm). Because the alive cells are excluded from staining (clear 
cytoplasm), this method is called dye exclusion method (159). The method though 
cannot distinguish between necrotic and apoptotic cells. Cells are evaluated by light 
microscopy.  
 
3.5.4 Annexin V/Propidium Iodide staining 
In the early stages of apoptosis changes occur at the cell surface such as the 
translocation of   phosphatidylserine (PS) from the inner side of the plasma membrane 
to the external surface of the cell. Annexin V, a protein with high affinity for PS, can be 
used as a sensitive probe for PS exposure upon the cell membrane. Furthermore, the 
exposure of PS to the external surface of the cells, occurs also in necrosis. Because the 
main difference between early stages of apoptosis and necrosis is the cellular 
membrane integrity, the measurement of Annexin V binding to the cell surface has to 
be performed together with a dye exclusion test that establishes the membrane integrity 
(160, 161). Consequently, the cells that PI−/Annexin V+ are  defined as being in early 
apoptosis whereas cells with PI+/Annexin V+ are counted as late apoptotic or 
secondary necrosis. Determination of annexin V binding is performed by flow 
cytometry or Fluorescence Activated Cell Sorting (FACS). FACS is a method used for 
the evaluation of cell-membrane proteins, intracellular proteins as well as peptides and 
DNA. The basic principle behind FACS is an antigen-antibody reaction, where the 
antibodies are fluorescently labeled. In a FACS analysis a labeled colored suspension 
of cells passes a focuses laser beam where the label is stimulated. The emitted 
florescent light from the flurophores, which are coupled to the antibodies, and the 
scattered-light are detected separately. 
 
3.6 CYTOKINE SECRETION 
In the event of inflammation, cells of the immune system are activated. Nanoparticles 
are recognized the immune cells due to their surface properties and composition, and 
eventually an immune response is mount. Consequently, the immune cells are 
responding to the presence of nanoparticles in the same way as to the presence of a 
pathogen or a foreign substance, by releasing chemical messengers (mostly proteins) 
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called cytokines (117, 162, 163).  Enzyme-linked immunosorbent assay (ELISA) is an 
enzymatic assay that uses antiboby – antigen reaction. It can be used either to detect the 
presence of proteins recognized by an antibody or to test for antibodies that recognize 
an antigen (the variant used in our studies).  
 
3.7 ASSESSMENT OF CELLULAR UPTAKE 
3.7.1 Qualitative assessment 
Electron microscopy, besides being an important tool for characterization of 
materials, is important for the comprehensive identification of the nano-bio 
interactions. TEM facilitates in depth analysis of the morphology and functional state 
of the cells following the uptake of nanomaterials. Furthermore, TEM can provide 
evidence of nanomaterials being / or not encapsulated in nanocarriers and their 
intracellular localization based on their high electron density (164, 165). Due to the 
use of ultrathin sections (50 – 100 nm) the technique provides a high-resolution 
visualization of the internal structure of the cells with the price of losing the 
dimensional information for structures bigger than the thickness of the section. 
Another important factor to remember in analyzing TEM images is the variability of 
the images imposed by the inherent inhomogeneity and anisotropy of the biological 
structures (166).  
 
3.7.2 Quantitative assessment 
Inductively coupled plasma mass spectrometry (ICP-MS) is a highly sensitive method 
that can measure concentrations below one part in 10
12
 (part per trillion) of analytes. 
The method is coupling the ICP for ionization of the elements with mass spectrometer 
for separation and detection of ions. Due to its high sensitivity and very low detection 
limit the method ICP-MS is used for quantification of cellular uptake of 
nanoparticles. Even though is an excellent quantitative tool, it is a destructive 
technique, prior digestion of the cells and dissolving of nanoparticles being part of the 
sample preparation in order to separate the analytes from the matrix. Furthermore, the 
technique cannot differentiate between internalized or just adsorbed on the cellular 
membrane nanoparticles (165, 167, 168).  
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3.8 PROTEOMIC ASSESSMENT OF BIO – CORONA 
Two main approaches are used in mass spectrometry based proteomics. In top – down 
proteomics the intact proteins are analyzed. However, the most common design of the 
proteomic assessment of the bio – corona by mass spectrometry is a bottom – up 
approach. This approach, also known as shotgun proteomics, is based on enzymatic 
cleavage of proteins into peptides, usually by trypsin, to facilitate the ionization and 
fragmentation for the subsequent identification of the proteins. 
When assessing the biocorona acquired by the nanoparticles in a biological 
environment, prior MS measurements, a thermal and chemical denaturation of the 
proteins is performed using a surfactant in low concentrations. Apart from denaturation 
by disrupting the hydrogen, hydrophobic and electrostatic bonds of the proteins, the 
surfactant is disrupting the same type of interactions of the proteins with the 
nanoparticles surface. Two mains methodologies are then used for obtaining the 
peptides that will be submitted form MS. One approach is using an intermediate step of 
separating by 1D electrophoresis. Following an in gel digestion, the peptides are 
subjected for analysis to MS (169). The other approach is the on - particles digestion 
approach where the proteins   are denatured, reduced, alkylated and trysinised directly 
from the surface of nanoparticles without the intermediate step of in gel trypsinisation 
(170).    
 
3.8.1 Mass spectrometry 
Mass spectrometry is a central analytical technique for protein research and for the 
study of biomolecules in general (171, 172).  
A mass spectrometer consists of an ion source, a mass analyzer that measures the mass-
to-charge ratio (m/z) of the ionized analytes, and a detector that registers the number of 
ions at each m/z value. The peptides are separated according to their mass, partially 
fragmented in amino acids and then by combining the fragmentation data with the mass 
data obtained, the amino acid sequence of each peptide is obtained. The identified 
peptide masses are then searched against a protein database of in silico digested 
peptides to match, based on the characteristic mass of a peptide with a certain sequence, 
the peptides with known proteins(172). Prefractionation by chromatographic separation 
is applied prior MS analysis to the mixture of peptides obtained after the trypsinisation 
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of the proteins to reduce the complexity of the peptide mixture and to increase the 
sensitivity of the technique.  
A relative quantification of the proteins by MS (comparing individual peptides/proteins 
between the experiments) is done either label free or using isotopic labeling. The 
advantage of using isotope labeling is the possibility to pool the samples so that the 
technical variability is reduced, the quantitative analysis being performed in one 
spectrum and not between several spectra.   
 
3.8.2 Bioinformatics 
The results from a mass spectrometry based proteomics are a long list of identified 
and/or quantified proteins. In order to translate these results into functional analysis and 
other possible biologically relevant analysis, the use of bioinformatics tools is 
necessary. Bioinformatics analysis starts with a matrix or sheet of quantitative 
measurements of protein levels expressed as peptide counts from the mass 
spectrometer. Rows in the matrix denote proteins and columns represent samples, such 
as protein corona from certain nanoparticle. 
 
Statistical tests, such as t-test, can then be used to determine which proteins are 
differentially bound to various types of nanoparticles. In order to be applicable, 
sufficient numbers of biological replicates need to be present. Statistical tests are an 
example of supervised methods of analysis because external information about the 
samples is used to predefine classes of observations. Clustering analysis is a set of 
techniques that seeks to divide the data into groups based on the patterns inherent in the 
data itself and can be termed an unsupervised method of data analysis. Hierarchical 
clustering starts from the bottom up to connect most similar observations together and 
proceeds to connecting groups or clusters of observations together to build up a tree 
where the most similar observations or proteins are close together. Other methods such 
as k-means, self organizing maps (SOM) or partitioning around medoids (PAM) allot 
samples or proteins into predefined number of bins. The number of bins can be 
determined from the data itself or by trial and error. 
 
Ontologies are structural frameworks used for organizing information in a domain 
using a common vocabulary and classifications to define objects, concepts and their 
properties and relations. Gene Ontology (GO) project consequently provides a 
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structured, precisely deﬁned, common, controlled vocabulary for describing the roles of 
genes and gene products (proteins) in any organism (173). It is divided into three 
independent ontologies: molecular function (MF), biological process (BP) and cellular 
component (CC) (174) a protein being linked to one or several categories in the same 
branch.  
 
KEGG (Kyoto Encyclopedia of Genes and Genomes) is another bioinformatics 
resource for understanding higher-order functional meanings and utilities of the cell or 
the organism from its genome information (174). KEGG describes mainly proteins 
interaction networks that are responsible for various cellular processes.  
 
Groups of proteins obtained based on statistical analysis or clustering can be analyzed 
for the over-representation of certain classes of proteins. Over-represented classes of 
proteins, such as KEGG pathways or GO categories, describe the proteins from a set 
that appear more often than would be expected by chance alone, when using the so 
called hypergeometric test to calculate the odds. Thus using additional software (such 
as Ingenuity pathways analysis) can help organizing a set of proteins (for example the 
proteins identified in protein corona) into groups of molecular functions, biological 
processes, pathways to discover common features in the proteins of interest such as 
enrichment relative to a proteins set. 
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4 RESULTS 
 
4.1 PAPER I. HIGH QUALITY AND TUNEABLE SILICA SHELL – 
MAGNETIC CORE NANOPARTICLES SYNTHESIS AND 
CHARACTERIZATION 
 
In this study, synthesis of core – shell particles with a single core of iron oxide 
nanoparticle and tunable silica shell thickness via inverse microemulsion method is 
achieved. An investigation on the factors that affect the separation and 
monodispersity of the core shell particles and the growth of silica shell is conducted.  
 
SPION nanoparticles with average size of 9.5 (±1.2) nm are obtained by the 
procedures described in 3.1.1 section. The High Resolution Transmission Electron 
Microscopy (HRTEM) images analysis matches the XRD measurements confirming 
that the nanoparticles composition is an iron oxide phase: either magnetite (Fe3O4) 
(ICDD#: 00-002-1035) and maghemite (γ-Fe2O3) (ICDD#: 00-013-0458) which have 
very close crystalline structure (spinel structure) and consequently is difficult to 
discriminate by this analysis. 
 
SPION were used as core for the fabrication of core-shell nanocomposites in an inverse 
(water/oil) microemulsion Triton-X100/hexanol/water/cyclohexane system. The 
hydrophobic oleic acid capping on the surface of SPION make them easily dispersible 
in cyclohexane, which is the continuous phase (oil phase) of the next step in the 
synthesis process: the inverse microemulsion synthesis. Triton-X100/hexanol are used 
as surfactant / co-surfactant couple. 
   
The hydrodynamic conditions were studied and no significant influence of the stirring 
rate on the size dispersion and homogeneity of core-shell nanoparticles formation was 
observed although it seemed to have an important role in the stability of the 
microemulsion system. Furthermore, we studied the variation of silica shell thickness 
as a function of time, the amount of TEOS and the SPION core size being maintained 
constant. For the identical set of initial conditions, the thickness of the silica shell 
increases linearly with time, reaching a constant value after 17h and remaining almost 
constant if the reaction time is further increased. 
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One important drawback of the microemulsion method is the fact that the resulting 
core-shell nanocomposites are strongly necked due to residual reactions leading to 
formation of silica layer connecting particles together (40, 49, 50, 52, 53, 175). A 
combination of two pH adjustment of the aqueous phase in the pH range of 1-2 (176) 
and the kinetic destabilization of the microemulsion by shock cooling highly separated, 
non-aggregated magnetic core - silica shell nanoparticles were obtained.  
 
A comprehensive magnetic characterization was performed on the core – shell 
nanoparticles with different silica shell thickness. The core-shell nanocomposites 
retained the superparamagnetic character of the magnetic core particles, the 
magnetization per unit weight of sample decreasing as the thickness of the silica shell is 
increasing for the same magnetic core size of SPION. Relaxivity studies performed on 
the core – shell particles revealed values for the r2/r1 ratios of ~ 3.5 fold higher than 
those of Resovist at 0.47T (20 MHz) and ~ 6 times higher than those of Feridex at 
0.47T (20 MHz) which indicates higher T2 contrasting characteristics of the core shell 
suspensions.  
 
In summary, we successfully synthesized core–shell nanoparticles with a narrow size 
distribution, a crystalline magnetic core and a tunable amorphous, porous silica shell 
thickness.  The carefully adjusted post-synthesis processing resulted in core–shell 
nanoparticles highly separated, with no residual aggregation. Magnetic measurements 
showed a superparamagnetic character with sufficiently high magnetization, 
rendering them useful for biomedical applications as biomedical targeting and 
imaging (e.g. magnetically driven drug delivery systems, MRI contrast agents, cell 
separation, etc.).  
 
4.2 PAPER II. EFFICIENT INTERNALISATION OF SILICA - COATED IRON 
OXIDE NANOPARTICLES OF DIFFERENT SIZES BY PRIMARY 
HUMAN MACROPHAGES AND DENDRITIC CELLS 
 
In this study, an investigation is performed on the effect of the size and the surface 
coating of the SPION on the biocompatibility and intracellular internalization in 
human primary macrophages and human primary dendritic cells. De novo synthesized 
silica coated SPIONs (CSNPs) with overall diameter of 30 nm, 50 nm, 70 nm, and 
 40 
120 nm were compared with cluster type dextran-coated iron oxide nanoparticles 
(nanomag®-D-spio) with two average sizes of the cluster of  20 nm and 50 nm.  
 
The hydrodynamic diameter of the CSNPs increased upon incubation in cell culture 
media, compared to the diameter measured in deionized (DI) water, whereas the 
hydrodynamic sizes of nanomag®-D-spio samples remained similar in the two 
dispersion media. The surface charge on CSNPs and nanomag®-D-spio evaluated in 
DI water showed that CSNPs were negatively charged in the pH range of 4 - 9, 
reaching −22 mV at physiological pH. (124). Nanomag®-D-spio showed a small 
positive charge below pH 6.3, exhibiting surface potential of approximately −3 mV at 
physiological pH (177).  
 
The superparamagnetic character of the core nanoparticles is retained in the case of 
nanomag®-D-spio nanoparticles and for CSNPs when the silica thickness increases 
although the value of the weight normalized Ms value is decreasing when the silica 
shell thickness is increasing. The r2/r1 ratios at 20 MHz obtained for CSNPs 
nanoparticles are higher when compared with reported values in the literature of 
commercially available T2 contrast while for nanomag®-D-spio the values are 
comparable. 
 
Whereas the mitochondrial function in primary human macrophages and the cell 
vibility in primary dendritic cells are not affected upon incubation with nanomag®-
D-spio, cellular type dependent results are obtained after incubation with various 
sizes of CSNPs. The mitochondrial function of primary human macrophages was 
decreased just when exposed to higher doses of 100 μg/mL, while an increase in cell 
death of the human dendritic cells was observed for smaller sized CSNPs (30 nm and 
50 nm) in a dose dependent manner. The results indicate a higher sensitivity of the 
dendritic cells compared to macrophages when exposed to smaller particles. 
Additionally, the production of pro – inflammatory cytokines: TNF-α in both cell 
types, and cytokines IL-6 (human primary macrophages) or IL-12 (human dendritic 
cells) was not induced after incubation with the nanoparticles for 24h and 48h. 
 
The qualitative assessment by TEM of internalization of CSNPs and nanomag®-D-
spio revealed a rapid internalization of CSNPs of all three sizes in primary 
macrophages and dendritic cells after 2h. The intracellular localization of the particles 
   41 
in endocytic vesicles directs towards an active uptake mechanism. In contrast, the 
internalization of nanomag®-D-spio in both cell types could be observed just after 24 
h incubation time. The quantification of the uptake process by ICP-MS revealed 
significantly higher cellular internalization of CSNPs when compared to nanomag®-
D-spio in human macrophages and dendritic cella, in a size and time dependent 
manner. The significant decrease in uptake of CSNPs after pretreatment of the cells 
with cytochalasin D provided an additional proof of an active internalization process 
involved. 
 
To conclude, de novo synthesized silica coated CSNPS exhibited a cell type 
dependent toxicity with low cytotoxicity towards primary macrophages but with size, 
dose and time dependent toxicity in dendritic cells. Furthermore, involving an active 
process, and indicating a possible surface effect, silica-coated nanoparticles are 
internalized by a greater degree than the dextran coated nanoparticles in both cell 
types, in a time dependent manner.  
 
4.3 PAPER III. COMPREHENSIVE ANALYSIS OF THE CORONA OF 
PALSMA PROTEINS ON SUPERPARAMAGNETIC IRON OXIDE 
NANOPARTICLES WITH DIFFERENT SURFACE COATINGS 
 
The influence of the surface coating of SPION on the protein corona composition as 
well as on the cytotoxicity and uptake in human primary macrophages cultivated in the 
absence of fetal calf serum (FCS) was addressed in this work. Silica coated core shell 
nanoparticles with an overall size of ~ 50 nm and dextran coated nanomag®-D-spio 
with cluster size of 50 nm were used in this study. 
The protein corona was formed upon in vitro incubation of the nanoparticles with 
pooled human plasma for 1 h, at 37°C. Centrifugation was used to separate the loosely 
bound “soft” corona from the “hard” corona attached on the surface of nanoparticles. 
The negative staining of the proteins revealed a nanoparticles’ surface dependent 
structural disposition of the protein corona: organized around the CSNPs and a diffuse 
appearance, visible as an organic layer on the whole micrographs in the case of 
nanomag®-D-spio.  
 
Both CSNP and nanomag®-D-spio increased their hydrodynamic size after the addition 
of protein corona, although the mean hydrodynamic diameter of CSNPs - protein 
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corona increased 3-fold while the increase is not so significant for nanomag®-D-spio. 
The presence of the protein corona increases the zeta potential for the CSNP to -11,2 
mV while for nanomag®-D-spio the value decreases to -9,8 mV.  
 
The influence of the protein corona formation on the magnetic properties was 
investigated. For CSNPs - protein corona the r2/r1 values increase with 57 % at 20 MHz 
and 63 % at 60 MHz compared with CSNPs while for nanomag®-D-spio and 
nanomag®-D-spio - protein corona the values are increasing with maxim 1%. 
 
The mitochondrial function of human primary macrophages was decreased in a time- 
and concentration-dependent manner upon exposure to CSNPs. In contrast, the 
mitochondrial function remains unaffected after exposure to CSNPs - protein corona, 
nanomag®-D-spio and nanomag®-D-spio - protein corona. Furthermore, no significant 
release of TNF – α was detected after incubation of the cells with the nanoparticles and 
nanoparticles – protein corona. The qualitative assessment of the internalization of the 
nanoparticles without and with protein corona could not visualize intracellular 
localization of nanomag®-D-spio and nanomag®-D-spio - protein corona particles 
whereas the CSNPs and CSNPs - protein corona are situated in membrane – enclosed 
vesicles. 
Mass spectrometry performed on protein corona extracted from CSNPs and 
nanomag®-D-spio by on nanoparticle digestion showed a high reproducibility in 
protein identification with 72.8% (±2) overlap of identified proteins for nanomag®-D-
spio and 71.9% (±5.7) for CSNPs from the no labeled analysis and calculated average 
standard deviations for the iTRAQ experiment of 14% for CSNP and 16% for 
nanomag®-D-spio.  
The use of bioinformatics tools (statistical analysis, clustering analysis, Pathway and 
Gene Ontology (GO) enrichment analysis using Webgestalt tool and Ingenuity pathway 
analysis) revealed a high specificity of the protein corona to the surface of the 
nanoparticles. The extracted proteins were grouping in clusters that revealed an 
enrichment of the inflammatory proteins in the CSNPs corona and cell adhesion and 
tight junction related proteins in the nanomag®-D-spio corona.  
Taken together, our data shows that the protein corona on the surface of the 
nanoparticles decreases the cytotoxicity (in the case of CSNPs) towards primary human 
   43 
macrophages. Although by MS specific proteins are found to be enriched on the surface 
of the two different nanoparticles, no correlation between the presence of a particular 
protein in the protein corona and the observed biological effects can be identified at this 
stage and further investigation are thus warranted. 
 
4.4 PAPER IV. SYNTHESIS, STURCTURAL AND MAGNETIC 
CHARACERISATION OF TRANSPARENT MAGNETIC IRON 
OXIDE/PMMA NANOCOMPOSITE 
 
In this study, we report on the synthesis of homogeneous transparent FeOx/PMMA 
nanocomposites by in-situ polymerization. Magnetic and magneto-optical 
properties of the nanocomposites were investigated. 
 
Oleic acid capped iron oxide nanoparticles with a mean diameter of ~ 26 nm and 
magnetite as dominant phase are obtained. The nanocomposite resulted is 
macroscopically slight brownish and transparent.  
 
TGA and DSC analysis revealed that FeOx-PMMA nanocomposite with various 
iron oxide loading exhibit enhanced thermal stability compared to PMMA alone in 
the temperature range of 200–375 °C due to the presence of iron oxide 
nanoparticles.  
 
The magnetic characterization of the composite by Angular Gradient Magnetometer 
showed an increase of the magnetization saturation/weight with the increase in the 
iron oxide loading with a remanence magnetization directly proportional to the 
inorganic nanoparticles loading. Furthermore, the Faraday rotation measurements 
showed the highest rotation of ca 0.5 deg/mm for the samples with the highest 
loading. As the rotation angle is proportional to the distance travelled by the light, a 
larger thickness of material with the same loading, or a higher loading of iron oxide 
nanoparticles, would be required for a substantial Faraday effect. 
 
UV – Vis measurements were performed on the nanocomposites with different iron 
oxide loadings.  The nanocomposites with a high loading of nanoparticles showed 
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absorption in the violet/blue region of the spectrum while lower loading 
nanocomposites have low absorption in the yellow/red. 
 
To conclude, homogeneous transparent nanostructured materials were obtained and 
their physicochemical characterization was performed showing their magneto – 
optical possible applications such as for the fabrication of micro actuators, sensors, 
relays and magnetooptical devices.  
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5 DISCUSSION 
 
Ideally, the design and the synthesis of a specific nanostructured material are pursued 
having a specific application as “target”. The work presented in this thesis is an 
example of designing and preparing core – shell nanoparticles with defined 
characteristics and investigating in vitro all the possible implications of using their 
suspension as MRI contrast agent.  
 
The necessity for synthesis of nanoparticles with well-controlled size and morphology 
is one of the basic requirements when advanced applications as in nanomedicine are 
desired. These applications also call for nanoparticles with more complex architecture 
such as core–shell structures that can carry several components with different 
functionality. Superparamagnetic iron oxide nanoparticles (SPION) are one of the 
most researched particles for applications in biology, medical diagnostics and therapy 
(178, 179). Surface-modified SPION are FDA approved materials for biological 
applications (180, 181). Silica is one of the preferred materials for coating the 
magnetic nanoparticles due to its high bio-stability, very low toxicity and versatile 
possibilities for surface functionalization via exposed silanol groups. In Paper I we 
developed a successful and reproducible fabrication route of finely tunable shell core 
– shell nanoparticle intended for magnetic visualizations applications. Understanding 
the synthesis mechanism was essential for a high reproducibility of the synthesis 
process. The formation of single iron oxide core - silica shell nanoparticles is the 
result of a controlled phase transfer of the cores in the water droplets of the dispersed 
phase and the subsequent homogeneous silica coating. Adjusting post synthesis the 
pH of the reaction in the region of minimum condensation of silica precursor and 
shock cooling the microemulsion resulted in highly separated particles, with no 
residual aggregation. The possibility that these nanoparticles might be used as MRI 
contrast agent are confirmed by the magnetic characteristics of the obtained 
nanoparticles such as superparamagnetism regardless of the silica thickness, high 
r2/r1 values compared to the commercial MRI contrast agents. 
 
In order to promote a safe use of nanomaterials in biomedical applications, the 
nanoparticles interactions with the cells is important to address (182, 183). As 
macrophages and dendritic cells are important immune system components (184), 
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primary human monocyte derived macrophages (HMDM) and dendritic cells 
(MDDC) are more relevant in vitro model systems compared to the transformed cell 
lines. In paper II we studied the effect of SPIONs with different sizes on the primary 
human immune cells. The core shell nanoparticles synthesized using the method 
described in paper I (30 nm and 50 nm) and a combination of microemulsion method 
with silica condensation in water system (70 nm and 120 nm) were compared with 
cluster type, dextran coated SPIONs (nanomag®-D-spio) commercially available and 
similar to clinically used SPIONs. Dextran coated SPION exhibited very good 
biocompatibility in HMDM and HMDD, the viability of the immune cells being 
unaffected by the presence of nanomag®-D-spio in the cell culture media, as well as 
no release of proinflamatory citokines being observed. While no cytokine release was 
observed in HMDM and MDDC after exposure to CSNPs, a dose, time and cellular 
type dependent toxicity in primary human immunocompetent cells is observed. To 
discriminate between a true size dependent toxicity effect observed in HMDD and 
possible interferences with the remnant chemicals from the different synthesis 
process, particles with similar sizes with the 50 nm particles synthesized via inverse 
microemulsion method were synthesized in a similar way as the 120 nm particles. As 
no toxicity induced by possible remnant ethanol from the synthesis / post processing 
could be observed, a size dependent toxicity was concluded. However, other possible 
contaminants (in undetectable quantities but with toxic effect) from the synthesis 
cannot be excluded. Cellular internalization was investigated as the use as MRI 
contrast agent of SPION is one of the possible applications.  The uptake (via an active 
process) seemed to be depending on the surface charge of the SPIONs as CSNPs were 
internalized to a much higher degree compared to nanomag®-D-spio. The observed 
differences in the hydrodynamic diameter of the nanoparticles dispersed in DI water 
and cell culture media as well as the surface dependent uptake contributed to the 
design of the following study (Paper III). 
 
In paper III we questioned whether the corona of proteins formed on the surface of 
nanoparticles immediately after the nanoparticles enter in contact with biological 
fluids (136) has potential role in changing the magnetic properties and biological 
responses. For this study, we compared CSNPs with a diameter of approx. 50 nm and 
dextran coated nanomag®-D-spio with a cluster size of 50 nm. The incubation of the 
nanoparticles with pooled human plasma and the consequent washing process 
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allowed obtaining just the particles with a stable, “hard” corona, which were used for 
the subsequent experiments. Relevant for the use of these materials under in vivo 
conditions as MRI contrast agents, the magnetic properties and the contrasting 
properties (r2/r1 ratio) are measured. Alteration of the magnetic properties of the 
nanoparticles by the presence of the protein corona is observed. The modifications 
detected can be related to the presence of the protein corona and with the processing 
conditions for obtaining the nanoparticle-protein corona complexes. To assess the 
differences in toxicity of the nanoparticles without and with protein corona, the 
human primary macrophages were incubated in the absence of fetal calf serum. A 
dose - and time - dependent toxicity was seen for CSNPs without protein corona.  A 
good biocompatibility was recorded though when cells were incubated with 
nanoparticle-corona complexes probably due to the presence of the protein corona and 
the decrease of the surface charge in the presence of the protein corona (185-187). The 
CSNPs non - toxicity in the presence of the protein corona is similar with the results in 
the paper II, where the fetal calf serum was the source of the proteins. The nanomag®-
D-spio was similarly, non-cytotoxic, without or with protein corona. Cytokine 
measurements showed no significant release of TNF-α after incubation of the HMDM 
in the presence of silica or dextran coated SPIONs without or with protein corona, 
although effects on other cytokines or other soluble mediators cannot be excluded. 
Furthermore, the comprehensive analysis of the protein corona formed on the two types 
of particles using proteomics analysis was complemented by the use of bioinformatics 
tools.  The analysis revealed a different distinct composition of the protein corona 
formed on the two types of particles, nanomag®-D-spio and CSNPs that might have 
possible very different implication in the biological responses. The protein corona 
extracted from the CSNPs surface is enriched in proteins implicated in complement, 
coagulation cascade and opsonisation as: complement components (3, 4A, 1q,9) and 
thrombin, coagulation factor XII, fibrinogen and apolipoproteins. These proteins are 
also important for opsonisation and subsequent uptake by the immune cells but also in 
systemic reactions as thrombosis and anaphylaxis (188, 189). This might correlate with 
the observed higher uptake of CSNPs – protein corona when compared to the 
nanomag®-D-spio – protein corona but also with the pristine CSNPs. Protein corona 
extracted from the nanomag®-D-spio surface is enriched in specific proteins different 
than the one obtained from the surface of CSNPs explained by the different surface 
charge. Enrichment of the cellular component cytoplasm and KEGG pathways focal 
cell adhesion and tight junction including integrins involved in caveolar mediated 
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endocytosis signaling may indicate that the nanomag®-D-spio protein corona is able to 
specifically interact with caveolae on the cell surface. We cannot conclude at this point 
in this work (and from the literature) if the observed interactions and effects on the cells 
are results of a specific component in biocorona or is a non specific effect (190). 
 
In paper IV we synthesized 3D nanostructures in which iron oxide nanoparticles are 
dispersed in a PMMA matrix. The dispersed iron oxide nanoparticles are having a size 
of 26 nm above the superparamagnetic limit for iron oxide (around 15 nm) which is 
important when obtaining ferromagnetic composites is desired. Furthermore, the 
dispersed nanoparticles are having oleic acid as surface capping which renders their 
dispersibility in  the monomers/oligomers during the in-site polymerization process 
(191) and close interaction with the organic phase. This is reflected from the TGA and 
DSC analysis that shows an enhanced thermal stability of the nanocomposites 
compared to the pure polymer probably due to the strong interfacial interactions 
between the polymer molecules and inorganic fillers. Due to the small size of inorganic 
nanoparticles and the homogeneous distribution of the nanoparticles in the polymer 
matrix, the nanocomposite has a good optical transparency proved by absorbance 
measurements.  The UV-Vis spectroscopy on the composites showed characteristic 
UV-shielding properties of PMMA under 400 nm wavelength. The nanocomposites 
with high concentration of iron oxide absorb light in violet/blue region due to the strong 
absorbance of the nanoparticles in this region. When the distance between the 
nanoparticles decrease (correspondingly the concentration decreases) the absorbance 
shift towards yellow/red region of the spectrum that might render them applicable for 
magneto-optical application in this wavelength region.  
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6  CONCLUSIONS 
 
In summary, the main results of this thesis are: 
 
 Core shell nanoparticles with single iron oxide core and a finely tunable silica 
shell were synthesized via inverse microemulsion method. The prepared 
particles have a narrow size distribution, no aggregation retained and 
superparamagnetic character with sufficiently high magnetization, rendering 
them useful for biomedical applications, specifically as MRI T2 contrast 
agents.  
 
 The core shell nanoparticles, exhibited a good biocompatibility when 
incubated in vitro with primary human immunocompetent cells. Furthermore, 
the cellular internalization of CSNPs by the human macrophages and dendritic 
cells is significantly higher compared to the internalization of the commercial 
dextran coated SPION, rendering them suitable for applications as MRI and 
cellular tracking. 
 
 The coating of the SPION determined the formation of plasma protein coronas 
with distinct composition. Furthermore, the protein corona has an impact on 
the magnetic characteristics of the nanoparticles as well as on cell viability of 
human primary macrophages, effects more significantly observed for the 
CSNPs.  
 
 3D homogeneous transparent nanostructures with well dispersed iron oxide 
nanoparticles in the polymer matrix have been synthesis. The high bulk 
homogeneity and optical transparency, along with good magnetic properties 
makes them useful for magneto – optical applications. 
 
Several nano-scale drug delivery systems eg. liposomal drug formulations of anti-
cancer drugs and contrast agents for MRI based on nanoparticles are FDA approved 
today and already in use in clinics and many more are in different stages of 
development for targeting, diagnostic or therapeutic applications. Assessing the 
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interaction of nanomaterials with the biological systems is a key step in developing new 
nanomedicines (either new drugs nanoparticles based or imaging contrast agents) and 
evaluating their safety. Due to their specific properties (size, surface charge and surface 
molecules, shape, stability) nanoparticles have the capacity to cross biological barriers, 
to interact with the immune system, to be uptake intracellular and to affect the cellular 
functions. Furthermore, there is an emerging understanding in the literature that the 
observed effects of nanoparticles in nanomedicine are due to a combination between 
the intrinsic characteristics of the nanoparticles and the presence of an acquired corona 
of biomolecules in different biological media. Consequently, their essential properties 
that recommended them for certain applications (ex the ability to modify the relaxation 
rate of protons for MRI contrast agents) might be altered/changed by the adsorbed 
biocorona. This is particularly important for contrast agents with enhanced contrasting 
characteristics in vitro that might show different performances in the presence of 
biomolecules in vivo conditions.  
 
In this thesis we combined the design and synthesis of nanoparticles for potential 
application as contrast agents in MRI with the assessment of the physical and chemical 
characteristics (size, surface charge, surface coating) and their magnetic characteristics. 
We investigated the influence of inherent characteristics of the nanoparticles on the 
interactions with immune cells as well as their in vitro biocompatibility in the 
absence/presence of proteins (fetal calf serum proteins and plasma). Modulation of their 
original magnetic properties was observed in the presence of the plasma protein corona. 
We conducted a comprehensive study of the composition of the protein corona and 
even if no correlation between the presence of a particular protein in the protein corona 
and the observed biological effects could be identified at this stage, further 
investigations are warranted. These studies contribute to the knowledge on the 
importance played by the biomolecules adsorbed on the surface of nanoparticles in 
triggering various responses in biological environment, in the incentive of developing 
better and safe nanoparticles for nanomedicine.  
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